Posted BY: Kara | NwoReport

The U.S. Centers for Disease Control and Prevention (CDC) has highlighted concerns about the new variant of the Wuhan coronavirus, BA.2.86, which poses a potential threat to fully vaccinated individuals. This variant specifically affects those who have received previous vaccinations for different strains of the virus or have tested positive for previous forms using Chinese-made test kits. The CDC warns that the large number of mutations in this variant raises concerns about its ability to evade existing immunity from vaccines and past infections, potentially making it more dangerous, particularly in individuals with compromised immune systems due to vaccination.

However, due to the limited availability of virus samples for laboratory testing of antibodies, the real-world impacts of BA.2.86 on immunity remain uncertain. The timing of this announcement coincides with concerns that vaccinated individuals might become susceptible to various diseases due to a vaccine-induced reduction in immunity, referred to as antibody-dependent enhancement (ADE) or vaccine-induced AIDS.

Trending: Mugshot of Donald Trump

The CDC does not attribute the recent increase in hospitalizations in the United States to the BA.2.86 variant, suggesting that other factors might be contributing. Speculations arise about the degradation of immune systems among the fully vaccinated, rendering them susceptible to infections that would typically be mild. Some reports indicate increased instances of unusual blood clots among vaccinated individuals.

This news aligns with plans from pharmaceutical companies to introduce booster shots in response to the variant. Amidst uncertainties about BA.2.86, concerns persist regarding the overall effectiveness of vaccinations and the long-term consequences of reduced immune responses in the fully vaccinated population. As fall and winter approach and natural sunlight exposure decreases, the anticipation of increased sickness and potential hospitalizations among vaccinated individuals continues. The situation raises questions about the interplay between viral mutations, immunity, and the effectiveness of vaccination strategies.